← Back to Search

Depression Screening for Depression

N/A

Recruiting

Led By Sidney Hankerson, MD, MBA

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adults 18 years and older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured at 3- and 6-months post-screening

Awards & highlights

Study Summary

This trial will test whether screening for depression in black churches by Community Health Workers, with referral to treatment if necessary, is more effective than referral as usual in terms of treatment engagement.

Who is the study for?

This trial is for English-speaking adults over 18 in Black church communities who may be experiencing depression, as indicated by specific questionnaire scores. It's not open to those already in formal mental health treatment or individuals with active suicidal thoughts, homicidal ideation, or psychotic symptoms.Check my eligibility

What is being tested?

The study compares two approaches: usual referral methods versus a more involved process called SBIRT (Screening, Brief Intervention, and Referral to Treatment) conducted by Community Health Workers. The effectiveness on engaging patients with depression treatments will be measured.See study design

What are the potential side effects?

Since this trial involves screening and referrals rather than medication or medical procedures, there are no direct side effects from interventions like you might expect with drug trials.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured at 3- and 6-months post-screening

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured at 3- and 6-months post-screening

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at 3- and 6-months post-screening for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Treatment Engagement

Secondary outcome measures

Change in Anxiety Severity

Change in Depressive Severity

Change in Depressive Symptoms

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SBIRTExperimental Treatment1 Intervention

SBIRT will involve screening with the Patient Health Questionnaire-9 (PHQ-9); brief intervention with Motivational Interviewing (MI); and referral to specialty treatment, as needed for subjects with persistent depressive symptoms.

Group II: Referral As UsualActive Control1 Intervention

Referral as Usual will involve distributing depression educational materials (e.g., from the National Institute of Mental Health) and contact information for treatment providers in our target community

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

SBIRT

2012

Completed Phase 2

~4990

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,431 Previous Clinical Trials

2,460,233 Total Patients Enrolled

47 Trials studying Depression

37,603 Patients Enrolled for Depression

National Institute of Mental Health (NIMH)NIH

2,783 Previous Clinical Trials

2,688,527 Total Patients Enrolled

665 Trials studying Depression

250,834 Patients Enrolled for Depression

Sidney Hankerson, MD, MBAPrincipal Investigator - Columbia University

Columbia University

Media Library

Referral as Usual Clinical Trial Eligibility Overview. Trial Name: NCT04524767 — N/A

Depression Research Study Groups: SBIRT, Referral As Usual

Depression Clinical Trial 2023: Referral as Usual Highlights & Side Effects. Trial Name: NCT04524767 — N/A

Referral as Usual 2023 Treatment Timeline for Medical Study. Trial Name: NCT04524767 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are investigators currently looking for individuals to participate in this research?

"Correct, the online clinicaltrials.gov registry shows that this study is actively recruiting subjects. This trial was first announced on August 1st, 2021 and was last updated on August 11th, 2022. The study is looking for 600 participants from 2 sites."

Answered by AI

How many test subjects are being included in this experiment?

"The correct answer is that this research is actively looking for test subjects. The trial was originally announced on 8/1/2021, with the latest update being on 8/11/2022. They are looking to 600 individuals at 2 different locations."

Answered by AI